Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Sun Pharma Announces Acquisition of Checkpoint Therapeutics
Tuesday, March 11, 2025Sun Pharmaceutical Industries has announced an agreement to acquire Checkpoint Therapeutics cSCC is the second most common skin cancer in the US with around million cases annually Key risks include UV exposure and immune suppression
Amaran Biotech Enters into Agreement with Nippon Fine Chemical to Expand CDMO Capabilities
Friday, March 07, 2025Amaran Biotechnology has signed a Memorandum of Understanding MOU with Nippon Fine Chemical The agreement aims to strengthen collaboration in nanoparticlebased drug manufacturing while expanding services across Taiwan
ScPharmaceuticals Receives Approval on FUROSCIX® for Edema Treatment in Chronic Kidney Disease
Friday, March 07, 2025ScPharmaceuticals has announced that the US Food and Drug Administration FDA has approved a supplemental New Drug Application sNDA for FUROSCIX FUROSCIX is designed to support the management of oedema by restoring and maintaining fluid balance
Bioheng Therapeutics Gains Approval for CD7 UCAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukaemia/Lymphoma
Thursday, March 06, 2025Bioheng Therapeutics has received clearance from the US Food and Drug Administration FDA for its Investigational New Drug IND application CTD is a universal CART cell product targeting CD Developed from healthy donor cells it is designed to avoid fra...
Antengene Receives Approval on XPOVIO® (Selinexor) for Multiple Myeloma and Lymphoma Treatment
Wednesday, March 05, 2025Antengene has secured approval from Indonesias National Agency of Drug and Food Control BPOM for its New Drug Application NDA for XPOVIO selinexor XPOVIO is the first orally available selective inhibitor of the nuclear export protein XPO By blocking...
IQVIA Laboratories Advances Clinical Trials with Digital Innovation
Wednesday, March 05, 2025IQVIA Laboratories has launched Site Lab Navigator a suite of solutions designed to automate and streamline laboratory workflows for clinical trial sponsors and investigator sites At the core of this innovation is an eRequisition system that replaces...
WuXi Biologics Launches EffiX™ Platform to Advance Microbial Biologics Production
Tuesday, March 04, 2025WuXi Biologics has launched EffiX a new microbial expression platform designed to improve the production of recombinant proteins and plasmid DNA The EffiX platform is a proprietary microbial expression system developed by WuXi Biologics
Celltrion Receives Approval for Denosumab Biosimilars STOBOCLO® and OSENVELT®
Tuesday, March 04, 2025Celltrion has received approval from the US Food and Drug Administration FDA for its denosumab biosimilars STOBOCLO CTP denosumabbmwo and OSENVELT CTP denosumabbmwo STOBOCLO denosumabbmwo is a receptor activator of NFB ligand RANKL inhibitor
Laekna Secures Approval for LAE120 in Advanced Solid Tumours Treatment
Tuesday, March 04, 2025Laekna has received approval from the US Food and Drug Administration FDA for the Investigational New Drug IND application of LAE a novel USP inhibitor for the treatment of advanced solid tumours LAE is an allosteric and highly potent USP inhibitor
CARsgen Receives Approval for Satri-cel in Claudin18.2-Positive Gastric Cancer
Monday, March 03, 2025CARsgen Therapeutics has announced that the Center for Drug Evaluation CDE of Chinas National Medical Products Administration NMPA has granted Breakthrough Therapy Designation BTD to satricabtagene autoleucel satricel CT
